4.8 Article

Rapid and selective sampling of IgG from skin in less than 1 min using a high surface area wearable immunoassay patch

Journal

BIOMATERIALS
Volume 170, Issue -, Pages 49-57

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2018.03.039

Keywords

Microneedle; Microprojection; Skin; Immunoassay; Diagnosis; Minimally invasive

Funding

  1. Australian Research Council (ARC Centre of Excellence in Convergent Bio-Nanotechnology and Science) [CE140100036]
  2. National Health and Medical Research Council (NHMRC Development Project) [APP1075739]
  3. Australian Research Council (ARC Future Fellowship)
  4. Australian Research Council (ARC DECRA)

Ask authors/readers for more resources

Microprojection array (MPA) patches are an attractive approach to selectively capture circulating proteins from the skin with minimal invasiveness for diagnostics at the point-of-care or in the home. A key challenge to develop this technology is to extract sufficient quantities of specific proteins from within the skin to enable high diagnostic sensitivity within a convenient amount of time. To achieve this, we investigated the effect of MPA geometry (i.e. projection density, length and array size) on protein capture. We hypothesised that the penetrated surface area of MPAs is a major determinant of protein capture however it was not known if simultaneously increasing projection density, length and array size is possible without adversely affecting penetration and/or tolerability. We show that increasing the projection density (5000-30,000 proj. cm(-2)) and array size (4-36 mm(2)) significantly increases biomarker capture whilst maintaining of a similar level tolerability, which supports previous literature for projection length (40-190 gm). Ultimately, we designed a high surface area MPA (30,000 proj. cm(-2), 36 mm2, 140 mu m) with a 4.5-fold increase in penetrated surface area compared to our standard MPA design (20,408 proj. cm(-2),16 mm(2), 100 mu m). The high surface area MPA captured antigen-specific IgG from mice in 30 s with 100% diagnostic sensitivity compared with 10-30 min for previous MPA immunoassay patches, which is over an order of magnitude reduction in wear time. This demonstrates for the first time that MPAs may be used for ultra-rapid (<1 min) protein capture from skin in a time competitive with standard clinical procedures like the needle and lancet, which has broad implications for minimally invasive and point-of-care diagnostics. Crown Copyright (C) 2018 Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available